{"database": "openregs", "table": "documents", "rows": [["FDA-1999-D-0081-0002", "FDA", "FDA-1999-D-0081", "\"Guidance for Industry: Supplemental Guidance on Testing for Replication Competent Retrovirus in Retroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors;\" Availability", "Notice", "Notice of Data Availability", "2000-10-24T04:00:00Z", 2000, 10, null, null, "2025-07-01T21:48:06Z", "00-26670", 0, 0, "09000064804a6961"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1999-D-0081-0002"], "units": {}, "query_ms": 0.6169289699755609, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}